Cargando…

Cost-effectiveness of diagnostic laparoscopy for assessing resectability in pancreatic and periampullary cancer

BACKGROUND: Surgical resection is the only curative treatment for pancreatic and periampullary cancer, but many patients undergo unnecessary laparotomy because tumours can be understaged by computerised tomography (CT). A recent Cochrane review found diagnostic laparoscopy can decrease unnecessary l...

Descripción completa

Detalles Bibliográficos
Autores principales: Morris, Stephen, Gurusamy, Kurinchi S, Sheringham, Jessica, Davidson, Brian R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394561/
https://www.ncbi.nlm.nih.gov/pubmed/25888495
http://dx.doi.org/10.1186/s12876-015-0270-x
_version_ 1782366312948826112
author Morris, Stephen
Gurusamy, Kurinchi S
Sheringham, Jessica
Davidson, Brian R
author_facet Morris, Stephen
Gurusamy, Kurinchi S
Sheringham, Jessica
Davidson, Brian R
author_sort Morris, Stephen
collection PubMed
description BACKGROUND: Surgical resection is the only curative treatment for pancreatic and periampullary cancer, but many patients undergo unnecessary laparotomy because tumours can be understaged by computerised tomography (CT). A recent Cochrane review found diagnostic laparoscopy can decrease unnecessary laparotomy. We compared the cost-effectiveness of diagnostic laparoscopy prior to laparotomy versus direct laparotomy in patients with pancreatic and periampullary cancer with resectable disease based on CT scanning. METHOD: Model based cost-utility analysis estimating mean costs and quality-adjusted life years (QALYs) per patient from the perspective of the UK National Health Service. A decision tree model was constructed using probabilities, outcomes and cost data from published sources. One-way and probabilistic sensitivity analyses were undertaken. RESULTS: When laparotomy following diagnostic laparoscopy occurred in a subsequent admission, diagnostic laparoscopy incurred similar mean costs per patient to direct laparotomy (£7470 versus £7480); diagnostic laparoscopy costs (£995) were offset by avoiding unnecessary laparotomy costs. Diagnostic laparoscopy produced significantly more mean QALYs per patient than direct laparotomy (0.346 versus 0.337). Results were sensitive to the accuracy of diagnostic laparoscopy and the probability that disease was unresectable. Diagnostic laparoscopy had 63 to 66% probability of being cost-effective at a maximum willingness to pay for a QALY of £20 000 to £30 000. When laparotomy was undertaken in the same admission as diagnostic laparoscopy the mean cost per patient of diagnostic laparoscopy increased to £8224. CONCLUSIONS: Diagnostic laparoscopy prior to laparotomy in patients with CT-resectable cancer appears to be cost-effective in pancreatic cancer (but not in periampullary cancer), when laparotomy following diagnostic laparoscopy occurs in a subsequent admission. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12876-015-0270-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4394561
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43945612015-04-14 Cost-effectiveness of diagnostic laparoscopy for assessing resectability in pancreatic and periampullary cancer Morris, Stephen Gurusamy, Kurinchi S Sheringham, Jessica Davidson, Brian R BMC Gastroenterol Research Article BACKGROUND: Surgical resection is the only curative treatment for pancreatic and periampullary cancer, but many patients undergo unnecessary laparotomy because tumours can be understaged by computerised tomography (CT). A recent Cochrane review found diagnostic laparoscopy can decrease unnecessary laparotomy. We compared the cost-effectiveness of diagnostic laparoscopy prior to laparotomy versus direct laparotomy in patients with pancreatic and periampullary cancer with resectable disease based on CT scanning. METHOD: Model based cost-utility analysis estimating mean costs and quality-adjusted life years (QALYs) per patient from the perspective of the UK National Health Service. A decision tree model was constructed using probabilities, outcomes and cost data from published sources. One-way and probabilistic sensitivity analyses were undertaken. RESULTS: When laparotomy following diagnostic laparoscopy occurred in a subsequent admission, diagnostic laparoscopy incurred similar mean costs per patient to direct laparotomy (£7470 versus £7480); diagnostic laparoscopy costs (£995) were offset by avoiding unnecessary laparotomy costs. Diagnostic laparoscopy produced significantly more mean QALYs per patient than direct laparotomy (0.346 versus 0.337). Results were sensitive to the accuracy of diagnostic laparoscopy and the probability that disease was unresectable. Diagnostic laparoscopy had 63 to 66% probability of being cost-effective at a maximum willingness to pay for a QALY of £20 000 to £30 000. When laparotomy was undertaken in the same admission as diagnostic laparoscopy the mean cost per patient of diagnostic laparoscopy increased to £8224. CONCLUSIONS: Diagnostic laparoscopy prior to laparotomy in patients with CT-resectable cancer appears to be cost-effective in pancreatic cancer (but not in periampullary cancer), when laparotomy following diagnostic laparoscopy occurs in a subsequent admission. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12876-015-0270-x) contains supplementary material, which is available to authorized users. BioMed Central 2015-04-02 /pmc/articles/PMC4394561/ /pubmed/25888495 http://dx.doi.org/10.1186/s12876-015-0270-x Text en © Morris et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Morris, Stephen
Gurusamy, Kurinchi S
Sheringham, Jessica
Davidson, Brian R
Cost-effectiveness of diagnostic laparoscopy for assessing resectability in pancreatic and periampullary cancer
title Cost-effectiveness of diagnostic laparoscopy for assessing resectability in pancreatic and periampullary cancer
title_full Cost-effectiveness of diagnostic laparoscopy for assessing resectability in pancreatic and periampullary cancer
title_fullStr Cost-effectiveness of diagnostic laparoscopy for assessing resectability in pancreatic and periampullary cancer
title_full_unstemmed Cost-effectiveness of diagnostic laparoscopy for assessing resectability in pancreatic and periampullary cancer
title_short Cost-effectiveness of diagnostic laparoscopy for assessing resectability in pancreatic and periampullary cancer
title_sort cost-effectiveness of diagnostic laparoscopy for assessing resectability in pancreatic and periampullary cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394561/
https://www.ncbi.nlm.nih.gov/pubmed/25888495
http://dx.doi.org/10.1186/s12876-015-0270-x
work_keys_str_mv AT morrisstephen costeffectivenessofdiagnosticlaparoscopyforassessingresectabilityinpancreaticandperiampullarycancer
AT gurusamykurinchis costeffectivenessofdiagnosticlaparoscopyforassessingresectabilityinpancreaticandperiampullarycancer
AT sheringhamjessica costeffectivenessofdiagnosticlaparoscopyforassessingresectabilityinpancreaticandperiampullarycancer
AT davidsonbrianr costeffectivenessofdiagnosticlaparoscopyforassessingresectabilityinpancreaticandperiampullarycancer